Ten-year follow-up of helium ion therapy for uveal melanoma

American Journal of Ophthalmology
D H CharJ R Castro

Abstract

To examine the results of helium ion irradiation in 218 patients with uveal melanoma treated more than 10 years ago. A retrospective review was made of 218 patients (218 eyes) treated with helium ion radiation for uveal melanoma between 1978 and 1984. After helium ion irradiation, 208 (95.4%) of 218 eyes had local tumor control. Ten years after irradiation, 46 (22.4%) of 218 eyes had been enucleated; the majority of enucleations (37 of 46) resulted from anterior ocular segment complications. Ten years after radiation, 102 (46.8%) of the 218 patients were dead; 51 had non-melanoma-related deaths and 51 had died of metastatic melanoma. Best-corrected visual acuity after radiation was greater than 20/40 in 21 (23%) of 93 eyes of the patients who were alive and who had retained their eyes 10 or more years after treatment. In patients with tumors less than 6 mm in height and more than 3 mm distant from the nerve or the fovea, 13 (72%) of 18 retained visual acuity greater than 20/40. In contrast, only 11% of the patients with either thicker tumors or those close to the nerve or fovea retained that level of visual acuity. Helium ion irradiation of uveal melanoma is associated with good local tumor control and reasonable retention of t...Continue Reading

References

Jul 1, 1978·American Journal of Ophthalmology·D H Char
Aug 1, 1992·Ophthalmology·D R GuyerE S Gragoudas
May 1, 1992·Ophthalmology·E S GragoudasJ E Munzenrider
Feb 1, 1990·Archives of Ophthalmology·D H CharR D Stone
Jan 1, 1990·Klinische Monatsblätter für Augenheilkunde·R GuthoffK Lauritzen
Mar 1, 1989·Ophthalmology·U L KarlssonR Woodleigh
Apr 1, 1987·Ophthalmology·E S GragoudasA Koehler
Oct 1, 1983·Ophthalmology·D H CharG F Hilton
Jan 1, 1980·International Ophthalmology Clinics·S Packer, M Rotman
Feb 1, 1980·American Journal of Ophthalmology·D H CharA Schwartz
Jun 1, 1980·Ophthalmology·S Packer, M Rotman
Feb 1, 1995·American Journal of Ophthalmology·E S GragoudasV Taratuta
Nov 15, 1994·International Journal of Radiation Oncology, Biology, Physics·J T ParsonsR R Million
Jun 1, 1994·The Australian and New Zealand Journal of Surgery·H MameghanS Brook
Jul 15, 1993·International Journal of Radiation Oncology, Biology, Physics·J M QuiveyS M Kroll
Jul 15, 1993·International Journal of Radiation Oncology, Biology, Physics·M KleineidamL W Brady
Oct 1, 1996·American Journal of Ophthalmology·D H CharJ Quivey

❮ Previous
Next ❯

Citations

Nov 7, 2012·Medical Physics·Hermann FuchsDietmar Georg
Jul 2, 2003·American Journal of Ophthalmology·Devron H CharTheodore L Phillips
Feb 24, 2001·Transactions of the American Ophthalmological Society·D H CharJ B Crawford
Sep 25, 2001·The British Journal of Ophthalmology·D H CharJ B Crawford
Nov 26, 2002·The British Journal of Ophthalmology·C HaritoglouA J Mueller
Oct 24, 2001·The British Journal of Ophthalmology·L LumbrosoB Asselain
Dec 31, 2003·International Journal of Radiation Oncology, Biology, Physics·Karin MullerPeter Levendag
Oct 2, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·K DieckmannR Pötter
Jun 19, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Karin DieckmannRichard Pötter
Nov 19, 2005·Eye·L Lumbroso-Le RouicL Desjardins
May 7, 2013·The British Journal of Ophthalmology·Melinda Y Chang, Tara A McCannel
Aug 23, 2005·International Journal of Radiation Oncology, Biology, Physics·Karin MullerGré P M Luyten
Jan 24, 2012·Zeitschrift für medizinische Physik·Julia StröbeleDietmar Georg
Jan 1, 2011·PET Clinics·Gaia GrassettoDomenico Rubello
Dec 5, 2006·International Journal of Radiation Oncology, Biology, Physics·Naoki HirasawaHirohiko Tsujii
Mar 16, 2016·Journal of the Egyptian National Cancer Institute·Akhil KapoorHarvindra Singh Kumar
Jan 27, 2009·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Sohel SomaniE Rand Simpson
Apr 20, 2004·International Journal of Radiation Oncology, Biology, Physics·Khaled EmaraE Rand Simpson
Mar 28, 2006·American Journal of Ophthalmology·Daniel J WeisbrodE Rand Simpson
Sep 8, 2015·American Journal of Ophthalmology·Ido Didi FabianVictoria M L Cohen
Jun 9, 2004·American Journal of Ophthalmology·L KodjikianJ D Grange
May 1, 2004·Current Opinion in Ophthalmology·Carol L Shields, Jerry A Shields
Feb 27, 2009·Ophthalmology·Paul T FingerUNKNOWN Palladium-103 for Choroidal Melanoma Study Group
Nov 30, 2016·International Ophthalmology Clinics·Ronald W MilamAnthony B Daniels
Dec 21, 2005·International Ophthalmology Clinics·Devron H CharInder Daftari
Apr 21, 2012·Melanoma Research·Josep Maria CaminalJorge Arruga
Apr 14, 2016·Radiology and Oncology·Boris JancarDusica Pahor
May 10, 2006·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Jeffrey K McKennaGlen M Bowen
Feb 28, 2007·Cancer·Carlo Greco, Suzanne Wolden
Apr 13, 2000·Cancer Control : Journal of the Moffitt Cancer Center·M C Kincaid
Jun 3, 2017·Frontiers in Oncology·Pedro Grachinski Buiar, Sérgio Jobim de Azevedo
Mar 10, 2001·International Journal of Radiation Oncology, Biology, Physics·M FussJ D Slater
Jun 8, 2002·Progress in Retinal and Eye Research·J G Journée-de Korver, J E E Keunen
May 10, 2003·International Journal of Radiation Oncology, Biology, Physics·Subir NagUNKNOWN American Brachytherapy Society
Jun 28, 2003·International Journal of Radiation Oncology, Biology, Physics·Joachim BognerRichard Pötter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.